Moderna Inc (MRNA)
Financial leverage ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 18,426,000 | 25,858,000 | 24,669,000 | 7,337,000 | 1,589,420 |
| Total stockholders’ equity | US$ in thousands | 13,854,000 | 19,123,000 | 14,145,000 | 2,561,000 | 1,175,000 |
| Financial leverage ratio | 1.33 | 1.35 | 1.74 | 2.86 | 1.35 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $18,426,000K ÷ $13,854,000K
= 1.33
The financial leverage ratio of Moderna Inc has shown fluctuation over the past five years. In 2019, the ratio was 1.35, indicating that the company had a moderate level of financial leverage. However, by the end of 2020, the ratio increased significantly to 2.86, suggesting a substantial increase in financial leverage, which may indicate higher financial risk.
In the following years, the financial leverage ratio decreased, reaching 1.33 at the end of 2023. This downward trend in the ratio indicates a reduction in the company's reliance on debt financing compared to its equity, which could be seen as a positive sign of improved financial stability and lower risk.
Overall, the trend in Moderna Inc's financial leverage ratio shows fluctuation with a notable increase in 2020 followed by a subsequent decrease in the following years. Monitoring this ratio over time can provide insights into the company's financial strategy and risk management practices.
Peer comparison
Dec 31, 2023